RE: When this recovers11 Jan 2022 11:04
Agreed, it's really not worth reading today and probably not until the next RNS. That could be several things:
Ava6k early PK results
Next pro drug chosen for the clinic
Tweaked lft
Point news
Daewoong news
Other partners news
Who knows, actual investors know that Avacta had so much more than a covid test, time to turn off though, see you on the other side...